Login
HARROW, INC. logo

HARROW, INC.

harrow.com

What Do They Do?

Sells branded and compounded prescription medicines for eye conditions to eyecare professionals, pharmacies, and patients.

How Do They Make Money?

Customers buy prescription medicines through Harrow’s pharmacy, outsourcing facility and distribution partner; Harrow earns product revenue when goods ship, or on delivery under some contracts. It also earns revenue from intellectual-property licenses.

revenue
SegmentShareRevenue
Product Sales Net
Sold outright

100%
FY2022: 94%
Other Revenues
0.1%
FY2022: 5.7%

Who Are Their Customers?

Branded medicines generally go through third-party distributors to pharmacies and end users; compounded medicines are dispensed through Harrow’s pharmacy for patients or prepared for in-office use.

Do Revenues Turn Into Profits?

Not on paper. It lost $5.1M in FY2025, but brought in more cash than it spent: $43M of free cash flow.

Operating income, FY2025
11% of revenue
▲ +246% vs FY2024 ($8.8M, 4%)
Net income, FY2025
−2% of revenue
▲ +71% (Loss) vs FY2024 (−$17.5M, −9%)
Free cash flow, FY2025
16% of revenue
▲ Turned profitable vs FY2024 (−$23.8M, −12%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +39%
vs $71.6M in Q3 FY2025
Net income
▲ +857%
vs $1M in Q3 FY2025
Product sales, net share of revenue vs 99.8% in Q3 FY2025
  • Nov 9, 2026 Reduced full-year Adjusted EBITDA guidance Revenue guidance was reaffirmed at $350 million to $365 million, while Adjusted EBITDA guidance changed to more than $40 million from $80 million to $100 million.
  • Oct 1, 2026 Acquired TYRVAYA rights outside Japan Harrow paid $30.0 million at closing, with up to $70.0 million in additional sales-based milestone payments.

Growing. Revenue grew 3.8x in 4 years, from $72.5M in FY2021 to $272.3M in FY2025, about 39% a year.

Melt ownership Harrow moved from holding a minority stake and royalty rights in Melt to owning Melt’s drug candidates and including its research and development in consolidated results.

Revenue over time
Product Sales Net Other Revenues
$500M$250M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support